Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics, Inc. financial statements

Artiva Biotherapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 010-K
Net income−USD 83.86M10-K
Cash and equivalentsUSD 26.7M10-Q
Total debtUSD 10.94MEODHD

Artiva Biotherapeutics, Inc. financials on 6ix · Artiva Biotherapeutics, Inc. on 6ix